Zydus Lifesciences has informed that the financial results of the company for Q3 2024-25 (October - December 2024) will be declared on February 5, 2025. Post results Q&A session through webinar has been scheduled on the same day, February 5, 2025, at 4:00 pm. Dr. Sharvil Patel, Managing Director, the company would be hosting the call. The details to join the call are provided in the attached file. Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the audio recording of the earnings call will be available on the Company’s website at https://www.zyduslife.com/investorzone. The transcript of the call will also be available subsequently at https://www.zyduslife.com/investorzone.
The above information is a part of company’s filings submitted to BSE.
